High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis.

@article{Kocken2012HighriskHP,
  title={High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis.},
  author={Mari{\"e}lle Kocken and Margot H Uijterwaal and Anton Lm de Vries and Johannes Berkhof and Johannes C. F. Ket and Theo J. M. Helmerhorst and Chris J L M Meijer},
  journal={Gynecologic oncology},
  year={2012},
  volume={125 2},
  pages={500-7}
}
OBJECTIVE Currently, women treated for high-grade cervical intraepithelial neoplasia (CIN 2/3) are followed-up by cytology to monitor them for residual and recurrent (post-treatment) disease. This systematic review and meta-analysis determine the test performance of testing for high-risk types of the human papillomavirus (hrHPV), cytology and co-testing (combined hrHPV testing and cytology) in predicting high-grade post-treatment disease (CIN2+). METHODS Studies that compared at least two of… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

HPV testing in the context of post-treatment follow up (test of cure).

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology • 2016

Similar Papers

Loading similar papers…